Cargando…
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952717/ https://www.ncbi.nlm.nih.gov/pubmed/33707412 http://dx.doi.org/10.1038/s41408-021-00449-9 |
| _version_ | 1783663790079868928 |
|---|---|
| author | Bezerra, Evandro D. Lasho, Terra L. Finke, Christy M. Saliba, Antoine N. Elliott, Michelle A. Pardanani, Animesh D. Gangat, Naseema Mangaonkar, Abhishek A. Ketterling, Rhett P. Tefferi, Ayalew Solary, Eric Patnaik, Mrinal M. |
| author_facet | Bezerra, Evandro D. Lasho, Terra L. Finke, Christy M. Saliba, Antoine N. Elliott, Michelle A. Pardanani, Animesh D. Gangat, Naseema Mangaonkar, Abhishek A. Ketterling, Rhett P. Tefferi, Ayalew Solary, Eric Patnaik, Mrinal M. |
| author_sort | Bezerra, Evandro D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7952717 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79527172021-03-28 CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes Bezerra, Evandro D. Lasho, Terra L. Finke, Christy M. Saliba, Antoine N. Elliott, Michelle A. Pardanani, Animesh D. Gangat, Naseema Mangaonkar, Abhishek A. Ketterling, Rhett P. Tefferi, Ayalew Solary, Eric Patnaik, Mrinal M. Blood Cancer J Correspondence Nature Publishing Group UK 2021-03-11 /pmc/articles/PMC7952717/ /pubmed/33707412 http://dx.doi.org/10.1038/s41408-021-00449-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Bezerra, Evandro D. Lasho, Terra L. Finke, Christy M. Saliba, Antoine N. Elliott, Michelle A. Pardanani, Animesh D. Gangat, Naseema Mangaonkar, Abhishek A. Ketterling, Rhett P. Tefferi, Ayalew Solary, Eric Patnaik, Mrinal M. CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes |
| title | CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes |
| title_full | CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes |
| title_fullStr | CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes |
| title_full_unstemmed | CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes |
| title_short | CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes |
| title_sort | csf3r t618i mutant chronic myelomonocytic leukemia (cmml) defines a proliferative cmml subtype enriched in asxl1 mutations with adverse outcomes |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952717/ https://www.ncbi.nlm.nih.gov/pubmed/33707412 http://dx.doi.org/10.1038/s41408-021-00449-9 |
| work_keys_str_mv | AT bezerraevandrod csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT lashoterral csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT finkechristym csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT salibaantoinen csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT elliottmichellea csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT pardananianimeshd csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT gangatnaseema csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT mangaonkarabhisheka csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT ketterlingrhettp csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT tefferiayalew csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT solaryeric csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes AT patnaikmrinalm csf3rt618imutantchronicmyelomonocyticleukemiacmmldefinesaproliferativecmmlsubtypeenrichedinasxl1mutationswithadverseoutcomes |